PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

PPS Treatment Update

  1. 211 Posts.
    lightbulb Created with Sketch. 37
    Hello to All just an update there has been a delay in the manufacturing of PPS, I now have to wait a little longer to start the treatment hopefully around Xmas, I can tell you its been delayed due to meeting FDA Approval specifications for phase 3 Worldwide Clinical trials.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.